The African Development Bank has approved a grant of $500,000 to undertake a feasibility study into the first phase of a ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

In this Healio Video Perspective from Clinical Trials at the Summit, Christine Kay, MD, discusses phase 1/2 results for ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

June 26, 2025) - Millennial Potash Corp. (TSXV: MLP) (OTCQB: MLPNF) (FSE: X0D) ("MLP", "Millennial" or the "Company") is ...

The African Development Bank ( www.AfDB.org) has approved a grant of $500,000 to undertake a feasibility study into the first ...

Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined ...

In a nutshell A mammoth ivory boomerang discovered in a Polish cave is likely between 42,290 and 39,280 years old, making it ...

Approximately 150 subjects will be enrolled, receiving either the therapy or a placebo daily for a 52-week treatment period.

Software development has entered a new era—one where intuition and experience, while still valuable, are no longer enough.

Eddie D. Jarwolo, Executive Director of Naymote Partners for Democratic Development, has raised serious concerns about the current state of Liberia's National Identification (ID) Card system, calling ...